BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 23972821)

  • 21. The evaluation and treatment of first-episode psychosis.
    Sheitman BB; Lee H; Strous R; Lieberman JA
    Schizophr Bull; 1997; 23(4):653-61. PubMed ID: 9366001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
    Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
    Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.
    Mustafa S; Joober R; Lepage M; Iyer S; Shah J; Malla A
    Schizophr Res; 2018 Nov; 201():287-293. PubMed ID: 29706449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
    Üçok A; Kara İA
    Schizophr Res; 2020 Nov; 225():31-38. PubMed ID: 31653578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
    Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
    Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.
    Asian Network of Early Psychosis Writing Group
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):737-758. PubMed ID: 35451023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.
    Chan KK; Chin QP; Tang JY; Longenecker J; Hui CL; Chiu CP; Lam MM; Wong GH; Chen EY
    Early Interv Psychiatry; 2011 Nov; 5(4):324-34. PubMed ID: 21521490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
    Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
    J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When to initiate antipsychotic treatment for psychotic symptoms: At the premorbid phase or first episode of psychosis?
    Zhang T; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Xie B; Li C; Wang J
    Aust N Z J Psychiatry; 2021 Mar; 55(3):314-323. PubMed ID: 33143440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric hospitalization following antipsychotic medication cessation in first episode psychosis.
    Hayes JF; Osborn DP; Lundin A; Dalman C
    J Psychopharmacol; 2019 Apr; 33(4):532-534. PubMed ID: 30777499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early predictors for late hospitalizations up to 14 years after first episode psychosis.
    Strålin P; Skott M; Cullberg J
    Soc Psychiatry Psychiatr Epidemiol; 2021 Aug; 56(8):1371-1380. PubMed ID: 33263822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP).
    Pelayo-Terán JM; Gajardo Galán VG; de la Ortiz-García de la Foz V; Martínez-García O; Tabarés-Seisdedos R; Crespo-Facorro B; Ayesa-Arriola R
    Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):315-323. PubMed ID: 27796500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
    Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
    JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong.
    Hui CL; Tang JY; Leung CM; Wong GH; Chang WC; Chan SK; Lee EH; Chen EY
    Aust N Z J Psychiatry; 2013 Aug; 47(8):746-53. PubMed ID: 23612934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
    Andrade C
    J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication-adherent first-episode psychosis patients also relapse: why?
    Levy E; Pawliuk N; Joober R; Abadi S; Malla A
    Can J Psychiatry; 2012 Feb; 57(2):78-84. PubMed ID: 22340147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.
    Berger GE; Proffitt TM; McConchie M; Yuen H; Wood SJ; Amminger GP; Brewer W; McGorry PD
    J Clin Psychiatry; 2007 Dec; 68(12):1867-75. PubMed ID: 18162017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis.
    Ottesen A; T V Hegelstad W; Joa I; Opjordsmoen SE; Rund BR; Røssberg JI; Simonsen E; Johannessen JO; Larsen TK; Haahr UH; McGlashan TH; Friis S; Melle I
    Psychol Med; 2023 Apr; 53(6):2399-2408. PubMed ID: 37144963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.